Nymox Pharmaceutical
NYMX
#10337
Rank
S$23.36 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.36 Million, an increase over its 2021 earnings that were of -S$15.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-63.67%
2022 -S$8.36 Million-47.71%
2021 -S$15.98 Million6.61%
2020 -S$14.99 Million-10.91%
2019 -S$16.83 Million24.24%
2018 -S$13.54 Million-20.03%
2017 -S$16.94 Million2.71%
2016 -S$16.49 Million-63.86%
2015 -S$45.62 Million674.44%
2014 -S$5.9 Million-6.11%
2013 -S$6.28 Million-35.66%
2012 -S$9.76 Million-20.76%
2011 -S$12.31 Million38.33%
2010 -S$8.9 Million35.59%
2009 -S$6.57 Million11.8%
2008 -S$5.87 Million-12.94%
2007 -S$6.75 Million8.85%
2006 -S$6.2 Million36.5%
2005 -S$4.54 Million-4.4%
2004 -S$4.75 Million-14.58%
2003 -S$5.56 Million
2001 -S$4.08 Million-20.54%
2000 -S$5.13 Million21.72%
1999 -S$4.22 Million-25.56%
1998 -S$5.67 Million101.3%
1997 -S$2.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.25 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.55 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.41 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.84 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.76 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA